Cargando…
Anti-N-methyl D-aspartate receptor encephalitis presenting with the new-onset refractory status epilepticus
New-onset refractory status epilepticus (NORSE) is a rare entity referring refractory status epilepticus (SE) in a patient without a history of epilepsy or an apparent cause. Herein, we report on a 31-year-old young female of anti-N-methyl D-aspartate (NMDA) receptor encephalitis admitted with NORSE...
Autores principales: | Alemdar, Murat, Acar, Turkan, Dalkilic, Sule |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kare Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331237/ https://www.ncbi.nlm.nih.gov/pubmed/37435283 http://dx.doi.org/10.14744/nci.2021.70431 |
Ejemplares similares
-
Anti-N-methyl-d-aspartate Receptor Encephalitis Presenting as New-onset Refractory Status Epilepticus Responding to Rituximab in an Adolescent Girl
por: Panda, Prateek Kumar, et al.
Publicado: (2021) -
Encephalitis with Anti-SOX1 Antibodies Presenting with New-Onset Refractory Status Epilepticus
por: Cho, Hee-Jin, et al.
Publicado: (2019) -
Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19
por: Monti, Giulia, et al.
Publicado: (2020) -
Comment on “Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19”
por: Dinoto, Alessandro, et al.
Publicado: (2020) -
Limbic and new onset refractory tonic status epilepticus (NORSE) in anti-NMDAR encephalitis()
por: Kaplan, Peter W., et al.
Publicado: (2017)